Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity-Reference-Cited by-同舟云学术

Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity

Published:2018-01-08 Issue:1 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sankar Mari Jeeva¹,Sankar Jhuma²,Chandra Parijat³

Affiliation:

1. All India Institute of Medical Sciences; Newborn Health Knowledge Centre, WHO Collaborating Centre for Training and Research in Newborn Care, Department of Pediatrics; Delhi India

2. All India Institute of Medical Sciences; Department of Pediatrics; New Delhi New Delhi India

3. Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences (AIIMS); New Delhi Delhi India 110029

Publisher

Wiley

Subject

Pharmacology (medical)

Reference54 articles.

1. Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II;Autrata;European Journal of Ophthalmology,2012

2. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial;Geloneck;JAMA Ophthalmology,2014

3. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity;Mintz-Hittner;New England Journal of Medicine,2011

4. NCT00622726 Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity (BEAT-ROP) clinicaltrials.gov/ct2/show/NCT00622726

5. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity;Karkhaneh;Acta Ophthalmologica,2016

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating VEGF-A Levels in Relation to Retinopathy of Prematurity and Treatment Effects: A Systematic Review and Meta-Analysis;Ophthalmology Science;2024-11

2. Clinical Risk Factors for Retinopathy of Prematurity Reactivation after Intravitreal Antivascular Endothelial Growth Factor Injection;The Journal of Pediatrics;2024-10

3. Artesunate inhibits vasculogenic mimicry in choroidal melanoma through HIF-1 α/ VEGF/PDGF pathway;Acta Histochemica;2024-10

4. Incidence of Blepharoptosis Following Intravitreal Anti–Vascular Endothelial Growth Factor Injections;American Journal of Ophthalmology;2024-09

5. Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity;50 Studies Every Neonatologist Should Know;2024-09